CIK 0001635088 · Large accelerated filer
Roivant Sciences Ltd.
Sign in to watch- Ticker
- ROIV
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Mar 31
- Incorporated
- Bermuda
- Entity type
- operating
- EIN
- 981173944
- Phone
- 441-295-5950
- Business address
- 7TH FLOOR, 50 BROADWAY, LONDON, United Kingdom, SW1H 0DB
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $85,719,562
- in 13 filings, $45.5M under 10b5-1 plans
Net −$85,719,562. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-29 | Epperly Melissa B, Director | Option exercise 10b5-1 | +17,750 | $4.46 | $79K | 34,224 |
| 2026-06-29 | Epperly Melissa B, Director | Sale 10b5-1 | −15,002 | $34.32 | $515K | 19,222 |
| 2026-06-29 | Epperly Melissa B, Director | Sale 10b5-1 | −2,748 | $34.71 | $95K | 16,474 |
| 2026-06-29 | Epperly Melissa B, Director | Option exercise · Stock Option (Right to Buy) 10b5-1 | −17,750 | 169,166 | ||
| 2026-06-29 | MANCHESTER KEITH S Director | Sale | −200,000 | $34.44 | $6.9M | 14,301,546 |
| 2026-06-29 | MANCHESTER KEITH S Director | Sale | −600,000 | $34.59 | $20.8M | 13,701,546 |
| 2026-06-29 | Gold Daniel Allen Director | Sale | −200,000 | $34.44 | $6.9M | 14,301,546 |
| 2026-06-29 | Gold Daniel Allen Director | Sale | −600,000 | $34.59 | $20.8M | 13,701,546 |
| 2026-06-29 | QVT Financial LP Director by Deputization | Sale | −200,000 | $34.44 | $6.9M | 14,301,546 |
| 2026-06-29 | QVT Financial LP Director by Deputization | Sale | −600,000 | $34.59 | $20.8M | 13,701,546 |
| 2026-06-26 | MANCHESTER KEITH S Director | Sale | −300,783 | $33.92 | $10.2M | 14,826,546 |
| 2026-06-26 | MANCHESTER KEITH S Director | Sale | −325,000 | $34.07 | $11.1M | 14,501,546 |
| 2026-06-26 | Gold Daniel Allen Director | Sale | −300,783 | $33.92 | $10.2M | 14,826,546 |
| 2026-06-26 | Gold Daniel Allen Director | Sale | −325,000 | $34.07 | $11.1M | 14,501,546 |
| 2026-06-26 | QVT Financial LP Director by Deputization | Sale | −300,783 | $33.92 | $10.2M | 14,826,546 |
| 2026-06-26 | QVT Financial LP Director by Deputization | Sale | −325,000 | $34.07 | $11.1M | 14,501,546 |
| 2026-06-26 | Sukhatme Mayukh President & CIO | Option exercise | +500,000 | $3.85 | $1.9M | 19,177,617 |
| 2026-06-26 | Sukhatme Mayukh President & CIO | Sale | −500,000 | $34.08 | $17.0M | 18,677,617 |
| 2026-06-26 | Sukhatme Mayukh President & CIO | Option exercise · Stock Option (Right to Buy) | −500,000 | 14,224,363 | ||
| 2026-06-25 | Sukhatme Mayukh President & CIO | Option exercise | +500,000 | $3.85 | $1.9M | 19,177,617 |
Page 7 of 29 · 570 trades